Medical
Pharmaceutical
Research And Development

Madrigal Pharmaceuticals

$94.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$3.13 (-3.19%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell MDGL and other stocks, options, ETFs, and crypto commission-free!

About MDGL

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Read More The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Employees
17
Headquarters
West Conshohocken, Pennsylvania
Founded
2011
Market Cap
1.51B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
227.90K
High Today
$98.24
Low Today
$93.73
Open Price
$98.05
Volume
160.54K
52 Week High
$292.29
52 Week Low
$89.83

Collections

Medical
Pharmaceutical
Research And Development
Health
Cancer Prevention
Technology

MDGL Earnings

-$0.98
-$0.98
-$0.97
-$0.97
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.